πŸ‡ΊπŸ‡Έ FDA
Patent

US 10251923

Therapeutic uses of mastic gum fractions

granted A61KA61K31/745A61K36/22

Quick answer

US patent 10251923 (Therapeutic uses of mastic gum fractions) held by REGENERA PHARMA LTD. expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERA PHARMA LTD.
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/745, A61K36/22, A61P, A61P11/00